Comment on

• Long-term outcomes of sacral neuromodulation for lower urinary tract dysfunction: A 23-year experience.

  Gandhi S, Gajewski JB, Koziarz A, Almutairi S, Ali A, Cox A. Gandhi S, et al. Neurourol Urodyn. 2021 Jan;40(1):461-469. doi: 10.1002/nau.24583. Epub 2020 Nov 24. Neurourol Urodyn. 2021. PMID: 33232534
• Risk factors for urinary retention after urogynecologic surgery: A retrospective cohort study and prediction model.

  Zhang BY, Wong JMH, A Koenig N, Lee T, Geoffrion R. Zhang BY, et al. Neurourol Urodyn. 2021 Jun;40(5):1182-1191. doi: 10.1002/nau.24676. Epub 2021 Apr 23. Neurourol Urodyn. 2021. PMID: 33891339
• Efficacy of sacral neuromodulation and percutaneous tibial nerve stimulation in the treatment of chronic nonobstructive urinary retention: A systematic review.

  Ho FCS, He C, Yao HH, O'Connell HE, Gani J. Ho FCS, et al. Neurourol Urodyn. 2021 Jun;40(5):1078-1088. doi: 10.1002/nau.24694. Epub 2021 May 11. Neurourol Urodyn. 2021. PMID: 33973670
• Association between overactive bladder and pelvic organ mobility as evaluated by dynamic magnetic resonance imaging.

  Kinno K, Sekido N, Takeuchi Y, Sawada Y, Watanabe S, Yoshimura Y. Kinno K, et al. Sci Rep. 2021 Jul 2;11(1):13726. doi: 10.1038/s41598-021-93143-6. Sci Rep. 2021. PMID: 34215810 Free PMC article.
• Pelvic organ prolapse surgery and overactive bladder symptoms-a population-based cohort (FINPOP).

  Karjalainen PK, Tolppanen AM, Mattsson NK, Wihersaari OAE, Jalkanen JT, Nieminen K. Karjalainen PK, et al. Int Urogynecol J. 2022 Jan;33(1):95-105. doi: 10.1007/s00192-021-04920-w. Epub 2021 Jul 10. Int Urogynecol J. 2022. PMID: 34245317 Free PMC article.